Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0480
-0.0020 (-4.00%)
May 12, 2026, 2:47 PM AEST
Firebrick Pharma Market Cap
Firebrick Pharma has a market cap or net worth of 13.67 million as of May 12, 2026. Its market cap has decreased by -21.62% in one year.
Market Cap
13.67M
Enterprise Value
12.23M
Revenue
410.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since January 28, 2022, Firebrick Pharma's market cap has decreased from 89.49M to 13.67M, a decrease of -84.73%. That is a compound annual growth rate of -35.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 13.67M | 3.00% |
| Dec 30, 2025 | 13.27M | 1.87% |
| Dec 31, 2024 | 13.03M | 46.33% |
| Dec 29, 2023 | 8.90M | -77.12% |
| Dec 29, 2022 | 38.92M | -56.51% |
| Jan 28, 2022 | 89.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 48.90B |
| Sigma Healthcare | 32.67B |
| Pro Medicus | 13.54B |
| Sonic Healthcare | 9.36B |
| Neurotech International | 15.81M |
| Intelicare Holdings | 15.53M |
| OncoSil Medical | 15.35M |
| ImpediMed | 14.27M |